{"result": "(\"entity\"<|>HOSPITAL DIET<|>EVENT<|>Hospital diet refers to the dietary plans and choices made for patients in a hospital setting, including therapeutic and special diets.)\n##\n(\"entity\"<|>DIET BASAL<|>EVENT<|>The basal diet is a normal diet that is free and unrestricted for hospitalized patients.)\n##\n(\"entity\"<|>DIETAS TERAPÉUTICAS<|>EVENT<|>Therapeutic diets are specialized diets designed for patients with specific health conditions, which can be ordered with or without salt.)\n##\n(\"entity\"<|>DIETAS PROGRESIVAS<|>EVENT<|>Progressive diets are a group of diets that help patients recover digestive functions after fasting or prepare for diagnostic tests.)\n##\n(\"entity\"<|>DIETAS ESPECIALES<|>EVENT<|>Special diets are non-coded diets tailored to individual patient needs in a hospital setting.)\n##\n(\"entity\"<|>CONTROL METABÓLICO<|>EVENT<|>Metabolic control diets are designed to manage caloric intake, including options for 1500, 1800, 2000, and 2500 calories.)\n##\n(\"entity\"<|>CONTROL PROTEICO<|>EVENT<|>Protein control diets focus on specific protein intake levels, such as hyperproteic diets or those designed for patients undergoing dialysis.)\n##\n(\"entity\"<|>CONTROL GRASA<|>EVENT<|>Fat control diets limit fat intake, including options for low-fat diets.)\n##\n(\"entity\"<|>CONTROL RESIDUO<|>EVENT<|>Residue control diets are designed to minimize waste in the digestive system, including laxative diets.)\n##\n(\"entity\"<|>ONDONTOLOGICAL DIET<|>EVENT<|>Odontological diets are designed for patients with chewing or swallowing difficulties.)\n##\n(\"entity\"<|>TRITURADA DIET<|>EVENT<|>Crushed diets are for patients with severe chewing or swallowing difficulties.)\n##\n(\"entity\"<|>DIABETIC DIET FOR SMALL CHILDREN<|>EVENT<|>Diabetic diets for small children are tailored for children under 6 years with diabetes.)\n##\n(\"entity\"<|>DIABETIC DIET FOR LARGE CHILDREN<|>EVENT<|>Diabetic diets for larger children are designed for children over 6 years with diabetes.)\n##\n(\"entity\"<|>CELIAC DIET<|>EVENT<|>Celiac diets are designed for patients with gluten intolerance.)\n##\n(\"entity\"<|>LOW CHOLESTEROL DIET<|>EVENT<|>Low cholesterol diets are designed for patients with dyslipidemia.)\n##\n(\"entity\"<|>LACTOSE DIET<|>EVENT<|>Lactose diets are designed for patients with lactose intolerance.)\n##\n(\"entity\"<|>NO MEAT DIET<|>EVENT<|>No meat diets are designed for patients with meat intolerance.)\n##\n(\"relationship\"<|>HOSPITAL DIET<|>DIET BASAL<|>The hospital diet includes the basal diet as one of its options for patients<|>7)\n##\n(\"relationship\"<|>HOSPITAL DIET<|>DIETAS TERAPÉUTICAS<|>Therapeutic diets are a key component of the hospital diet plan<|>8)\n##\n(\"relationship\"<|>DIETAS TERAPÉUTICAS<|>DIETAS PROGRESIVAS<|>Progressive diets are a type of therapeutic diet used during recovery<|>6)\n##\n(\"relationship\"<|>DIETAS TERAPÉUTICAS<|>DIETAS ESPECIALES<|>Special diets are another category within therapeutic diets<|>5)\n##\n(\"relationship\"<|>CONTROL METABÓLICO<|>DIETAS TERAPÉUTICAS<|>Metabolic control diets are a specific type of therapeutic diet<|>7)\n##\n(\"relationship\"<|>CONTROL PROTEICO<|>DIETAS TERAPÉUTICAS<|>Protein control diets are included in the therapeutic diets<|>7)\n##\n(\"relationship\"<|>CONTROL GRASA<|>DIETAS TERAPÉUTICAS<|>Fat control diets are part of the therapeutic diets<|>7)\n##\n(\"relationship\"<|>CONTROL RESIDUO<|>DIETAS TERAPÉUTICAS<|>Residue control diets are also a type of therapeutic diet<|>7)\n##\n(\"relationship\"<|>ONDONTOLOGICAL DIET<|>DIETAS TERAPÉUTICAS<|>Odontological diets are a specific therapeutic diet for patients with chewing issues<|>6)\n##\n(\"relationship\"<|>TRITURADA DIET<|>DIETAS TERAPÉUTICAS<|>Crushed diets are another form of therapeutic diet for severe chewing issues<|>6)\n##\n(\"relationship\"<|>DIABETIC DIET FOR SMALL CHILDREN<|>DIETAS TERAPÉUTICAS<|>Diabetic diets for small children are a specialized therapeutic diet<|>6)\n##\n(\"relationship\"<|>DIABETIC DIET FOR LARGE CHILDREN<|>DIETAS TERAPÉUTICAS<|>Diabetic diets for larger children are also a specialized therapeutic diet<|>6)\n##\n(\"relationship\"<|>CELIAC DIET<|>DIETAS TERAPÉUTICAS<|>Celiac diets are a therapeutic diet for gluten intolerance<|>6)\n##\n(\"relationship\"<|>LOW CHOLESTEROL DIET<|>DIETAS TERAPÉUTICAS<|>Low cholesterol diets are a therapeutic diet for managing cholesterol levels<|>6)\n##\n(\"relationship\"<|>LACTOSE DIET<|>DIETAS TERAPÉUTICAS<|>Lactose diets are a therapeutic diet for lactose intolerance<|>6)\n##\n(\"relationship\"<|>NO MEAT DIET<|>DIETAS TERAPÉUTICAS<|>No meat diets are a therapeutic diet for meat intolerance<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: FR, SA-S-N, SGN, SBN, SAN |\n| FD- | Fácil digestión | 4ª fase de progresión | FDB, FDD |\n| 3-- | Transición | Antes de dieta completa | 3G-, 3B-, 3FR, 3A-3-N, 3GN, 3BN, 3AN |\n| ODN | Odontológica/fácil masticación | Problemas masticación/deglución leves | 18M |\n| T-- | Triturada | Problemas masticación/deglución mayores | TG-, TB-, 15T, TFR, TA-T-N |\n| HP- | Hiperproteica | Quemaduras, aumento de catabolismo, UPP | |\n| P40 | 40 gr proteínas | Patología renal/hepática | P4K, P4D |\n| P60 | 60 gr proteínas | Patología renal/hepática | P6K, P6D |\n| 150 | 1500 kcal | Control metabólico | |\n| 180 | 1800 kcal | Control metabólico | 18G, 18B, 18A |\n| 200 | 2000 kcal | Control metabólico | |\n| 250 | 2500 kcal | Control metabólico | |\n| DNP | Diabética niños pequeños | Niños con diabetes menores de 6 años | |\n| DNG | Diabética niños grandes | Niños con diabetes mayores de 6 años | |\n| RX- | Preparación rayos | Preparación pruebas radiológicas | 1RX, 2RX |\n| CEL | Celíaca | Intolerancia al gluten | |\n| COL | Pobre en colesterol | Dislipemias | |\n| LAX | Laxante | Estreñimiento | |\n| NC- | No carne | Intolerancia carne | |\n\nA: astringente; B: protección biliar; D: diabetes; FR: fraccionada; G: protección gástrica; K: pobre en potasio; M: fácil masticación; N: niños.\nNota: todas las dietas se pueden pedir con o sin sal.\n---\nTema 6. Planificación de la dieta hospitalaria 101\n\n## ELECCIÓN DE DIETA EN PACIENTE HOSPITALIZADO\n\n1. Dieta basal = normal = libre\n\n2. Dietas terapéuticas | Con/sin sal\n\n3. Dietas especiales = no codificadas\n\nFigura 1. Elección de dieta en paciente hospitalizado.\n\n## 2. DIETAS TERAPÉUTICAS\n\n| Tipo | Descripción |\n|------|-------------|\n| PROGRESIVAS | Líquida/semilíquida/semiblanda/blanda/transición |\n| MODIFICACIÓN TEXTURAS | Ondontológica/triturada |\n| CONTROL PROTEICO | Hiperproteica/40 gr proteína/60 gr proteína/Hemodiálisis/diálisis peritoneal |\n| CONTROL METABÓLICO | 1500/1800/2000/2500 calorías |\n| CONTROL RESIDUO | Laxante/pobre en residuo/sin residuo |\n| CONTROL GRASA | 100 gr grasa/pobre en grasa |\n| OTRAS RESTRICCIONES | Sin gluten/pobre en purinas/Ovolactovegetariana/Inmunodeprimidos |\n\nFigura 2. Dietas terapéuticas.\n\nrimientos de energía y nutrientes del paciente hospitalizado, teniendo en cuenta su situación fisiológica y patológica. Generalmente permite la elección entre dos opciones de cada plato, en comida y cena, con una rotación de 7 días y variaciones de algunos platos en función de los alimentos de temporada (tabla 2). Aporta aproximadamente 2200-2400 kcal, con una distribución de macronutrientes de 50-55% hidratos de carbono, 30-35% lípidos y 10-20% proteínas. A partir de los alimentos utilizados para elaborar la dieta basal se diseñarán los menús de las dietas terapéuticas.\n\n2. DIETAS PROGRESIVAS O DE TRANSICIÓN: término que engloba el grupo de dietas indicado en una etapa de recuperación de las funciones digestivas tras un período de ayuno, así como para la preparación de algunas pruebas diagnósticas (tabla 3 y figura 3). En función del tipo de cirugía/agresión, la zona afectada, el estado basal del paciente y la evolución clínica, el comienzo y la velocidad de progresión del plan dietético debe ser individualizado para cada paciente. Asimismo, en algunos casos, no será imprescindible pasar por cada uno de los pasos. Las principales diferencias en las distintas dietas que se explican a continuación son el tipo y textura de los alimentos, las tecnologías culinarias empleadas, las cantidades y el reparto de la ingesta a lo largo del día (tabla 4). En caso de mala tolerancia oral o de ingesta insu-\n---\n## BLOQUE: DIETOTERAPIA\n\n### Tabla 2. Modelo de menú de dieta basal.\n\n| LUNES | MARTES | MIÉRCOLES | JUE\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}